期刊文献+

Sp1在 NK/T 细胞淋巴瘤细胞株中的表达及其对细胞侵袭的影响

Expression of Sp1 in NK/T cell lymphoma cell lines and its influence on cell invasion
原文传递
导出
摘要 目的:观察转录因子 Sp1在 NK/T 细胞淋巴瘤(NK/TCL)细胞株中的表达及其对细胞侵袭的影响。方法采用实时荧光定量聚合酶链反应(PCR)、免疫荧光和 Western blot 法测定 NK/TCL 细胞株 SNK-1、SNK-6和健康人 NK 细胞中 Sp1的表达;采用 Sp1抑制剂光神霉素 A(MIT)作用于 NK/TCL细胞株后,用实时荧光定量 PCR 和 Western blot 法检测 Sp1、胰岛素样生长因子1受体(IGF-1R)和基质金属蛋白酶2(MMP-2)的表达;采用 Transwell 实验观察 MIT 对细胞侵袭力的影响。结果 NK/TCL 细胞株SNK-1、SNK-6中 Sp1基因和蛋白高表达。其中基因的表达水平分别是健康人 NK 细胞的(9.4±0.3)倍和(10.6±0.3)倍(P=0.0052,P=0.0037),蛋白的表达水平分别是健康人 NK 细胞的(5.4±0.3)倍和(8.6±0.5)倍(P=0.0083,P=0.0069)。100 nmol/L MIT 抑制 Sp1后,与二甲基亚砜处理的对照组相比,细胞株中 IGF-1R 的基因表达量分别下降了(83.9±3.7)%和(65.8±4.2)%(P=0.0082,P=0.0097),蛋白表达量分别下降了(51.5±7.1)%和(49.6±9.1)%(P=0.0178,P=0.0155)。100 nmol/L MIT 处理细胞后 SNK-1、SNK-6细胞的侵袭率分别下降了(29.6±6.4)%和(37.2±7.6)%(P=0.0418,P=0.0372),MMP-2蛋白表达量分别是对照组蛋白表达量的(52.7±4.7)%、(29.7±5.6)%(P=0.0286,P=0.0202)。结论 NK/TCL细胞株高表达 Sp1,其可能通过正调控 IGF-1R 增强 MMP-2的表达,进而提高 NK/TCL 细胞的侵袭力。 Objective To identify the expression of transcription factor Sp1 in NK/T-cell lymphoma (NK/TCL) cell lines and to investigate the role of Sp1 in regulation of cell invasion. Methods Real-time PCR, immunofluorescence and Western blot were performed to detect the expression of Sp1 in NK/TCL cell lines SNK-1 and SNK-6 and normal NK cells. Expression levels of IGF-1R and MMP-2 were measured by real-time PCR and Western blot, respectively. Transwell assay was applied to observe the effects of mythramycin A(MIT) on cell invasion. Results Sp1 expression in mRNA and protein were over-expression in NK/TCL cell lines SNK-1 and SNK-6 when compared with normal NK cells. Inhibition of Sp1 by MIT remarkably reduced expression of IGF-1R and MMP-2 in SNK-1, SNK-6 and as a result, or significantly suppressed cell invasion. Expression levels of Sp1 mRNA in SNK-1 and SNK-6 were (9.4±0.3) and (10.6±0.3) foldsincrease as compared with that of control group, respectively (P=0.005 2, P=0.003 7). Levels of Sp1 protein were (5.4±0.3) and (8.6±0.5) foldsincrease times than control groups, respectively (P=0.008 3, P=0.006 9). Inhibition of Sp1 by MIT (100 nmol/L) remarkably reduced expression levels of IGF-1R mRNA by (83.9±3.7) % and (65.8±4.2) % (P = 0.008 2, P = 0.009 7) as compared with controls. Meanwhile, levels of IGF-1R protein were reduced by (51.5±7.1) % and (49.6±9.1) % (P = 0.017 8, P = 0.015 5) as compared with control group. Inhibition of Sp1 by MIT (100 nmol/L) significantly reduced cell invasion and MMP-2 expression in the two cell lines,the cell invasion rates were reduced by (29.6±6.4) % and (37.2±7.6) % (P =0.041 8, P = 0.037 2) in SNK-1 and SNK-6 as compared with control group. The MMP-2 protein levels were found to be (52.7±4.7) % and (29.7±5.6) % (P = 0.028 6, P = 0.020 2) of control group. Conclusion Sp1 is over-expressed in NK/TCL cell lines, and it promotes NK/TCL cell invasion by up-regulating IGF-1R and further increasing MMP-2 expression.
出处 《白血病.淋巴瘤》 CAS 2016年第7期394-398,408,共6页 Journal of Leukemia & Lymphoma
关键词 NK/T 细胞淋巴瘤 转录因子 SP1 胰岛素生长因子 1 受体 光神霉素 A 细胞侵袭 Natural killer/T-cell lymphoma Transcription factor Spl Insulin-like growth factor 1receptor Cell invasion
  • 相关文献

参考文献15

  • 1William BM, Armitage JO. International analysis of the frequency and outcomes of NK/T-cell lymphomas [J]. Best Pract Res Clin Haematol, 2013, 26( 1 ): 23-32. DOI:lO.1016/j.beha.2013.04.003.
  • 2Sun J, Yang Q, Lu Z, et al. Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification [J]. Am J Clin Pathol, 2012, 138 (3): 429-434. DOI: 10.1309/AJCP7YLTQPUSDQ5C.
  • 3Jo JC, Yoon DH, Kim S, et al. Clinical features and prognostic model for extranasal NK / T-celllymphoma [J]. Eur J Haematol, 2012, 89 (2): 103-110. DOI:IO.1111/j.1600-0609.2012.01796.x.
  • 4Yang Y, Zhang Y J, Zhu Y, et al. Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study [J]. Leukemia, 2015, 29 (7): 1571-1577. DOI:10.1038/leu.2015.44.
  • 5Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes[J]. J Clin Oncol, 2008, 26(25): 4124-4130. DOI: 10.1200/JC O.2008.16.4558.
  • 6黄方,丁浩,常君,张文皓,陶荣.自分泌IGF-1/IGF-1R环路促进NK/T细胞淋巴瘤细胞株迁移和侵袭[J].白血病.淋巴瘤,2015,24(6):334-340. 被引量:4
  • 7Beitner-Johnson D, Werner H, Roberts CT, et al. Regulation of insulin-like growth factor I receptor gene expression by Spl: physical and functional interactions of Spl at GC boxes and at a CT element[J].Mol Endocrinol, 1995, 9(9) : 1147-1156. DOI: 10.1210/mend. 9.9.7491107.
  • 8Jiang Y, Wang L, Gong W, et al. A high expression level of insulin- like growth factor I receptor is associated with increased expression of transcription factor Spl and regional lymph node metastasis of human gastric cancer[Jl. Clin Exp Metastasis, 2004, 21 (8): 755- 764.
  • 9Chu PC, Kulp SK, Chen CS. Insulin-like growth factor- I receptor is suppressed through transcriptional repression and mRNA destabili- zation by a novel energy restriction-mimetic agent[ J ]. Carcinogenesis, 2013, 34( 12):2694-2705. DOI: 10.1093/carcin/bgt251.
  • 10Nair V, Sreevalsan S, Basha R, et al. Mechanism of metformin- dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) transcription factors [J]. J Biol Chem, 2014, 289 (40): 27692- 27701. DOI: 10.1074/jbc.M 114.592576.

二级参考文献23

  • 1Wang KF, Chang BY, Chen XQ, et al. A prognostic model based on pretreatment platelet lymphocyte ratio for stage I E/ [I E upper aerodigestive tract extranodal NK / T cell lymphoma, nasal type [ J ]. Med Oncol, 2014, 31 ( 12 ) : 318.
  • 2Kim M, Kim TM, Kim KH, et al. Ifosfamide, methotrexate, etoposide, and prednisolone ( IMEP ) plus L-asparaginase as a first- line therapy improves outcomes in stage ]lI/ IV NK/T cell- lymphoma, nasal type (NTCL) [J]. Ann Hematol, 2014, 94 ( 3 ) : 437-444.
  • 3Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer ! T-cell lymphoma study: pathology findings and clinical outcomes [ J ]. J Clin Onco, 2008, 26 ( 25 ) : 4124-4130.
  • 4Gryko M, Kisluk J, Cepowicz D, et al. Expression of insulin-like growth factor receptor type 1 correlate with lymphatic metastases in human gastric cancer [ J ]. Pol J Pathol, 2014, 65 ( 2 ) : 135-140.
  • 5Doopfner KT, Spertini O, Arcaro A. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway [ J ]. Leukemia, 2007, 21 ( 9 ) : 1921-1930.
  • 6Liang Z, Diepstra A, Xu C, et al. Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma [ J ]. PloS One, 2014, 9 ( 1 ) : e87474.
  • 7Batallle R, RobiUard N, Avet-Loiseau H, et al. CD221 ( IGF-1R ) is aberrantly expressed in multiple myeloma, in relation to disease severity [ J ]. Haematologica, 2005, 90 ( 5 ) : 706-707.
  • 8Nagata H, Konno A, Kimura N, et al. Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T / NK-cell lymphomas associated with the Epstein-Barr virus [ J ]. Blood, 2001, 97 ( 3 ) : 708-713.
  • 9Qiang YW, Yao L, Tosato G, et al. Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells [ J ]. Blood, 2004, 103( 1 ) : 301-308.
  • 10Yaktapour N, Ubelhart R, Schuler J, et al. Insulin-like growth factor- 1 receptor (IGFIR) as a novel target in chronic lymphocytic leukemia [ J ]. Blood, 2013, 122 ( 9 ) : 1621-1633.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部